Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series.
Allinovi M, Bellinvia A, Pesce F, Milan Manani S, Razzolini L, Brezzi B, Protopapa P, Mantero V, Caroti L, Cirami CL, Amato MP, Del Vecchio L. Allinovi M, et al. Among authors: bellinvia a. Brain Sci. 2021 Oct 11;11(10):1341. doi: 10.3390/brainsci11101341. Brain Sci. 2021. PMID: 34679405 Free PMC article.
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
Amato MP, Prestipino E, Bellinvia A, Niccolai C, Razzolini L, Pastò L, Fratangelo R, Tudisco L, Fonderico M, Mattiolo PL, Goretti B, Zimatore GB, Losignore NA, Portaccio E, Lolli F. Amato MP, et al. Among authors: bellinvia a. PLoS One. 2019 Oct 21;14(10):e0222929. doi: 10.1371/journal.pone.0222929. eCollection 2019. PLoS One. 2019. PMID: 31634346 Free PMC article.
Correction: Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
Amato MP, Prestipino E, Bellinvia A, Niccolai C, Razzolini L, Pastò L, Fratangelo R, Tudisco L, Fonderico M, Mattiolo PL, Goretti B, Zimatore GB, Losignore NA, Portaccio E, Lolli F. Amato MP, et al. Among authors: bellinvia a. PLoS One. 2019 Nov 14;14(11):e0225494. doi: 10.1371/journal.pone.0225494. eCollection 2019. PLoS One. 2019. PMID: 31725815 Free PMC article.
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
Amato MP, Fonderico M, Portaccio E, Pastò L, Razzolini L, Prestipino E, Bellinvia A, Tudisco L, Fratangelo R, Comi G, Patti F, De Luca G, Brescia Morra V, Cocco E, Pozzilli C, Sola P, Bergamaschi R, Salemi G, Inglese M, Millefiorini E, Galgani S, Zaffaroni M, Ghezzi A, Salvetti M, Lus G, Florio C, Totaro R, Granella F, Vianello M, Gatto M, Di Battista G, Aguglia U, Logullo FO, Simone M, Lucisano G, Iaffaldano P, Trojano M. Amato MP, et al. Among authors: bellinvia a. Brain. 2020 Oct 1;143(10):3013-3024. doi: 10.1093/brain/awaa251. Brain. 2020. PMID: 32935843
Cognitive Issues in Pediatric Multiple Sclerosis.
Portaccio E, De Meo E, Bellinvia A, Amato MP. Portaccio E, et al. Among authors: bellinvia a. Brain Sci. 2021 Mar 30;11(4):442. doi: 10.3390/brainsci11040442. Brain Sci. 2021. PMID: 33808278 Free PMC article. Review.
26 results